News

Article

In Israel, business continues amid conflict

Author(s):

CorNeat Vision is among the many companies working to try to maintain operations amid the conflict.

(Image Credit: AdobeStock/SeanPavonePhoto)

(Image Credit: AdobeStock/SeanPavonePhoto)

During periods of war or conflict, medical professionals are often the front-line workers whose impact can save lives.

Amid the fighting, business is also impacted by the conflict. Gilad Litvin, MD, an ophthalmologist, founder and chief medical officer of Ra'anana, Israel-based CorNeat Vision, noted that in the initial days of the war, all non-essential medical activities were halted.

“There were so many injured civilians in the hospital system that these activities did not take place,” he explained in an email interview with Ophthalmology Times. “Since then, the activities slowly returned to normal. No lack of products was encountered.”

Prior to the cease-fire, fighting created myriad problems for companies, and Litvin noted that Israeli citizens are accustomed to war and continue work activities as well as they can.

“At CorNeat Vision we have a crucial employee missing since the initiation of war due to reserve military service,” he said. “We are brainstorming ways to overcome. Current concerns mainly arise from the growing anti-Israeli and antisemitic sentiment which impacts activities from fundraising all the way to distribution and sales.”

Companies, including CorNeat Vision also are looking for ways to ensure business can continue amid the conflict.

We at CorNeat Vision try to share in the activities of our missing head of engineering,” Litvin said. “We amended our fundraising activities appropriately and are actively pushing our planned activities forward despite a growing risk profile.”

Amid conflict, Litvin noted that an atmosphere of war is not conducive to work in general and specifically kills creativity.

“This has had a minor impact on us until now, but we will be impacted as all of us at CorNeat Vision are going through a traumatic event,” he concluded. “We pray for peaceful times to come soon, and bring renewed prosperity, growth and all the boring stuff of ordinary life.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.